Disease areas
More about our work in Oncology
We are united around our mission to redefine the future of cancer treatment. Our goal is to help people facing cancer live longer, better lives.
By exploring new frontiers in science and technology, we strive to accelerate innovation of transformational medicines that deliver more years of life and quality of life for patients and families living with immune-mediated conditions.
Unlocking hope
With over 20 years of research under our belt, we have built a vast proprietary knowledge of disease biology.
By exploring new frontiers in science and technology, we strive to accelerate innovation of transformational medicines that deliver more years of life and quality of life for patients and families living with immune-mediated conditions.
Pioneering for patients
worldwide are affected by immune-mediated diseases1
of immune-mediated diseases
mistakenly attacks healthy cells and tissues
1 World Health Organization. (2020). Global Report on Immune-Mediated Diseases. https://www.who.int/publications/i/item/global-report-on-immune-mediated-diseases)
Our focus in immunology
All about Galapagos
Everything you need to know about Galapagos in one slide deck.
Multiple drug modalities
We are more passionate than ever about rapidly advancing and expanding our immunology pipeline, and want to brighten the horizon of possibilities with multiple modes-of-action and drug modalities.
We are evaluating CAR-T therapy for the treatment of refractory systemic lupus erythematosus and other chronic immune-mediated diseases to expand our cell therapy portfolio.
Disease areas
We are united around our mission to redefine the future of cancer treatment. Our goal is to help people facing cancer live longer, better lives.
Partnerships
We are adding new capabilities, technologies and product candidates through internal and external innovation. Let’s start #PioneeringForPatients, together!